IN2012DN06436A - - Google Patents

Info

Publication number: IN2012DN06436A
Authority: IN; India
Prior art keywords: acceptable salt; pharmaceutically acceptable; piperazine; pharmaceutically; dioxoethyl
Prior art date: 2004-03-24

Application number

Other languages

English (en)

Inventor

Lin Pin-Fang

Nowicka-Sans Beata

Yamanaka Gregory

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-24

Filing date

2005-03-01

Publication date

2015-10-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961940&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN06436(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-03-01 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2015-10-09 Publication of IN2012DN06436A publication Critical patent/IN2012DN06436A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

IN6436DEN2012 2004-03-24 2005-03-01 IN2012DN06436A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55576704P	2004-03-24	2004-03-24
PCT/US2005/006277 WO2005102392A2 (fr)	2004-03-24	2005-03-01	Methodes de traitement d'une infection a vih

Publications (1)

Publication Number	Publication Date
IN2012DN06436A true IN2012DN06436A (fr)	2015-10-09

Family

ID=34961940

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN6436DEN2012 IN2012DN06436A (fr)	2004-03-24	2005-03-01

Country Status (31)

Country	Link
US (1)	US7776863B2 (fr)
EP (1)	EP1732604B1 (fr)
JP (1)	JP4847441B2 (fr)
KR (1)	KR101158140B1 (fr)
CN (1)	CN1956720B (fr)
AR (1)	AR048333A1 (fr)
AT (1)	ATE474602T1 (fr)
AU (1)	AU2005235116B2 (fr)
BR (1)	BRPI0509140A (fr)
CA (1)	CA2561146C (fr)
CY (1)	CY1111613T1 (fr)
DE (1)	DE602005022420D1 (fr)
DK (1)	DK1732604T3 (fr)
ES (1)	ES2347801T3 (fr)
GE (1)	GEP20104925B (fr)
HK (1)	HK1096540A1 (fr)
HR (1)	HRP20100434T1 (fr)
IL (1)	IL178141A (fr)
IN (1)	IN2012DN06436A (fr)
MY (1)	MY144318A (fr)
NO (1)	NO337116B1 (fr)
NZ (1)	NZ549778A (fr)
PE (1)	PE20060148A1 (fr)
PL (1)	PL1732604T3 (fr)
PT (1)	PT1732604E (fr)
RU (1)	RU2367439C2 (fr)
SI (1)	SI1732604T1 (fr)
TW (1)	TWI347184B (fr)
UA (1)	UA88463C2 (fr)
WO (1)	WO2005102392A2 (fr)
ZA (1)	ZA200607959B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040110785A1 (en) *	2001-02-02	2004-06-10	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7745625B2 (en)	2004-03-15	2010-06-29	Bristol-Myers Squibb Company	Prodrugs of piperazine and substituted piperidine antiviral agents
US20060100209A1 (en) *	2004-11-09	2006-05-11	Chong-Hui Gu	Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100432A1 (en) *	2004-11-09	2006-05-11	Matiskella John D	Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
PL1942108T3 (pl)	2005-10-28	2014-03-31	Ono Pharmaceutical Co	Związek zawierający grupę zasadową i jego zastosowanie
ES2407115T3 (es)	2005-11-18	2013-06-11	Ono Pharmaceutical Co., Ltd.	Compuesto que contiene un grupo básico y uso del mismo
US7851476B2 (en) *	2005-12-14	2010-12-14	Bristol-Myers Squibb Company	Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7501419B2 (en) *	2006-04-25	2009-03-10	Bristol-Myers Squibb Company	4-Squarylpiperazine derivatives as antiviral agents
US7807671B2 (en) *	2006-04-25	2010-10-05	Bristol-Myers Squibb Company	Diketo-piperazine and piperidine derivatives as antiviral agents
US7572810B2 (en) *	2006-06-08	2009-08-11	Bristol-Myers Squibb Company	Alkene piperidine derivatives as antiviral agents
US7504399B2 (en)	2006-06-08	2009-03-17	Bristol-Meyers Squibb Company	Piperazine enamines as antiviral agents
WO2009158396A1 (fr) *	2008-06-25	2009-12-30	Bristol-Myers Squibb Company	Dérivés de la dicétopipéridine utilisés comme inhibiteurs de fixation du vih
ES2462403T3 (es)	2008-06-25	2014-05-22	Bristol-Myers Squibb Company	Diceto azolopiperidinas y azolopiperazinas como agentes anti-VIH
US20110293521A1 (en) *	2010-05-28	2011-12-01	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Anti-viral compositions and methods for administration
WO2012019003A1 (fr)	2010-08-06	2012-02-09	Bristol-Myers Squibb Company	Dérivés d'oxoacétyl pipérazinamide à substitution indole et azaindole
EP2646439B1 (fr)	2010-12-02	2016-05-25	Bristol-Myers Squibb Company	Amides d'alkyle comme inhibiteurs d'attachement du vih
US8436168B2 (en)	2011-01-31	2013-05-07	Bristol-Myers Squibb Company	Methods of making HIV attachment inhibitor prodrug compound and intermediates
US8685982B2 (en)	2011-04-12	2014-04-01	Bristol-Myers Squibb Company	Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors
ES2609579T3 (es)	2011-08-29	2017-04-21	VIIV Healthcare UK (No.5) Limited	Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
EP2751119B1 (fr)	2011-08-29	2016-11-23	VIIV Healthcare UK (No.5) Limited	Dérivés fusionnés de diamine bicyclique utilisés en tant qu'inhibiteurs de la fixation du vih
WO2013138436A1 (fr)	2012-03-14	2013-09-19	Bristol-Myers Squibb Company	Dérivés d'hydrazine cycliques en tant qu'inhibiteurs de fixation du vih
WO2014025854A1 (fr)	2012-08-09	2014-02-13	Bristol-Myers Squibb Company	Dérivés d'amide de pipéridine en tant qu'inhibiteurs de fixation du vih
ES2616432T3 (es)	2012-08-09	2017-06-13	VIIV Healthcare UK (No.5) Limited	Derivados de alquenos tricíclicos como inhibidores de la unión del VIH
EP2978763B1 (fr) *	2013-03-27	2018-03-07	VIIV Healthcare UK (No.5) Limited	Utilisation de dérivés 2-céto amides comme inhibiteurs de fixation du vih
CN113648410A (zh) *	2015-06-23	2021-11-16	西托戴恩股份有限公司	Ccr5受体竞争性抑制剂、其应用和治疗方法
WO2023172635A1 (fr) *	2022-03-08	2023-09-14	Emory University	Modèle prédictif pour variants associés à la résistance aux médicaments et ses applications théranostiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1068219T3 (da) *	1998-03-02	2007-04-30	Univ North Carolina	Acylerede betulin- og dihydrobetulinderivater samt fremstilling og anvendelse deraf
US6476034B2 (en) *	2000-02-22	2002-11-05	Bristol-Myers Squibb Company	Antiviral azaindole derivatives
US20040110785A1 (en) *	2001-02-02	2004-06-10	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20030207910A1 (en) *	2001-02-02	2003-11-06	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
NZ533413A (en) *	2001-12-12	2006-09-29	Bristol Myers Squibb Co	HIV integrase inhibitors
JP4556020B2 (ja) *	2001-12-21	2010-10-06	ジェンザイム・コーポレーション	高い有効性を有するケモカインレセプタ結合複素環式化合物

2005
- 2005-02-24 US US11/064,683 patent/US7776863B2/en active Active
- 2005-03-01 WO PCT/US2005/006277 patent/WO2005102392A2/fr active Application Filing
- 2005-03-01 AU AU2005235116A patent/AU2005235116B2/en active Active
- 2005-03-01 EP EP05723932A patent/EP1732604B1/fr active Active
- 2005-03-01 DK DK05723932.9T patent/DK1732604T3/da active
- 2005-03-01 PT PT05723932T patent/PT1732604E/pt unknown
- 2005-03-01 DE DE602005022420T patent/DE602005022420D1/de active Active
- 2005-03-01 AT AT05723932T patent/ATE474602T1/de active
- 2005-03-01 ES ES05723932T patent/ES2347801T3/es active Active
- 2005-03-01 GE GEAP20059667A patent/GEP20104925B/en unknown
- 2005-03-01 KR KR1020067019595A patent/KR101158140B1/ko active IP Right Grant
- 2005-03-01 CA CA2561146A patent/CA2561146C/fr active Active
- 2005-03-01 JP JP2007504971A patent/JP4847441B2/ja active Active
- 2005-03-01 PL PL05723932T patent/PL1732604T3/pl unknown
- 2005-03-01 SI SI200531100T patent/SI1732604T1/sl unknown
- 2005-03-01 RU RU2006137555/14A patent/RU2367439C2/ru active
- 2005-03-01 BR BRPI0509140-3A patent/BRPI0509140A/pt not_active Application Discontinuation
- 2005-03-01 IN IN6436DEN2012 patent/IN2012DN06436A/en unknown
- 2005-03-01 CN CN2005800160669A patent/CN1956720B/zh active Active
- 2005-03-01 UA UAA200611163A patent/UA88463C2/ru unknown
- 2005-03-01 NZ NZ549778A patent/NZ549778A/en unknown
- 2005-03-17 MY MYPI20051136A patent/MY144318A/en unknown
- 2005-03-18 TW TW094108462A patent/TWI347184B/zh active
- 2005-03-23 AR ARP050101159A patent/AR048333A1/es active Pending
- 2005-03-28 PE PE2005000344A patent/PE20060148A1/es not_active Application Discontinuation
2006
- 2006-09-17 IL IL178141A patent/IL178141A/en active IP Right Review Request
- 2006-09-22 ZA ZA200607959A patent/ZA200607959B/en unknown
- 2006-10-06 NO NO20064547A patent/NO337116B1/no unknown
2007
- 2007-04-20 HK HK07104156.5A patent/HK1096540A1/xx unknown
2010
- 2010-08-03 HR HR20100434T patent/HRP20100434T1/hr unknown
- 2010-10-20 CY CY20101100937T patent/CY1111613T1/el unknown

Also Published As

Publication number	Publication date
CN1956720B (zh)	2010-12-15
WO2005102392A3 (fr)	2006-07-20
JP4847441B2 (ja)	2011-12-28
KR101158140B1 (ko)	2012-06-19
TWI347184B (en)	2011-08-21
NO20064547L (no)	2006-10-06
SI1732604T1 (sl)	2010-10-29
CY1111613T1 (el)	2015-10-07
UA88463C2 (ru)	2009-10-26
IL178141A0 (en)	2006-12-31
NZ549778A (en)	2010-09-30
ZA200607959B (en)	2008-06-25
AU2005235116A1 (en)	2005-11-03
KR20070011322A (ko)	2007-01-24
JP2007530540A (ja)	2007-11-01
RU2006137555A (ru)	2008-04-27
ATE474602T1 (de)	2010-08-15
HK1096540A1 (en)	2007-06-01
RU2367439C2 (ru)	2009-09-20
PT1732604E (pt)	2010-09-24
US20050215545A1 (en)	2005-09-29
CA2561146A1 (fr)	2005-11-03
EP1732604A2 (fr)	2006-12-20
HRP20100434T1 (hr)	2010-09-30
US7776863B2 (en)	2010-08-17
ES2347801T3 (es)	2010-11-04
AR048333A1 (es)	2006-04-19
CN1956720A (zh)	2007-05-02
NO337116B1 (no)	2016-01-25
EP1732604B1 (fr)	2010-07-21
DE602005022420D1 (de)	2010-09-02
PE20060148A1 (es)	2006-03-04
CA2561146C (fr)	2013-12-24
GEP20104925B (en)	2010-03-25
IL178141A (en)	2010-11-30
MY144318A (en)	2011-08-29
PL1732604T3 (pl)	2010-12-31
AU2005235116B2 (en)	2011-03-31
BRPI0509140A (pt)	2007-09-04
TW200538117A (en)	2005-12-01
DK1732604T3 (da)	2010-11-15
WO2005102392A2 (fr)	2005-11-03

Publication	Publication Date	Title
IN2012DN06436A (fr)	2015-10-09
WO2008054454A3 (fr)	2008-10-09	Dérivés hétérocycliques contenant de l'azote, compositions pharmaceutiques, et leurs procédés d'utilisations en tant qu'agents antiviraux
GEP20156282B (en)	2015-05-11	Compounds and compositions as protein kinase inhibitors
NZ627824A (en)	2016-02-26	Antiviral combinations involving (4r,12as)-n-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2hpyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
TW200621762A (en)	2006-07-01	Novel compounds
MXPA04006553A (es)	2004-10-04	Compuesto de 4-oxoquinolina y uso del mismo como inhibidor de integrasa de vih.
EA200601654A1 (ru)	2007-02-27	Ингибиторы интегразы вич
WO2007127635A3 (fr)	2008-03-13	Dérivés de dicéto-pipérazine et pipéridine en tant qu'agents antiviraux
MX2007003321A (es)	2007-06-05	Derivados heterociclicos y su uso como agentes terapeuticos.
GB0112348D0 (en)	2001-07-11	Compounds
WO2006086447A3 (fr)	2007-04-05	Derives de pyridazine et leur utilisation en tant qu'agents therapeutiques
SE0202463D0 (sv)	2002-08-14	Novel compounds
AP2002002455A0 (en)	2002-06-30	5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dIhydropyrazolo[4,3-D] pyrimidin-7-ones as phosphodiesterase inhibitors.
GEP20125701B (en)	2012-12-10	Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile
WO2008142055A3 (fr)	2010-04-22	Agents antiviraux
WO2004030611A3 (fr)	2004-06-17	Inhibiteurs non nucleosidiques de transcriptases inverses
GB0106661D0 (en)	2001-05-09	Pharmaceutically active compounds
CA2322900A1 (fr)	2001-04-11	Derives de substitution 2-(hetero)aryl purin-6-ones en tant qu'inhibiteurs de la phosphodiesterase
TW200745136A (en)	2007-12-16	4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
MX2007004248A (es)	2007-06-12	Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
EP2033954A4 (fr)	2009-08-12	Composé 6-(benzyle substituté par hétérocycle)-4-oxoquinoline et utilisation de celui-ci comme inhibiteur de l'intégrase du vih
CA2668320A1 (fr)	2008-05-08	Utilisation de 3-alpha-androstanediol, eventuellement en combinaison avec un agoniste 5-ht1a, dans le traitement du dysfonctionnement sexuel
SG155939A1 (en)	2009-10-29	Phosphoindoles as hiv inhibitors
UA96304C2 (en)	2011-10-25	2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
SG162614A1 (en)	2010-07-29	Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors